For: | Sood V, Bhansali A, Mittal BR, Singh B, Marwaha N, Jain A, Khandelwal N. Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods. World J Diabetes 2017; 8(7): 381-389 [PMID: 28751962 DOI: 10.4239/wjd.v8.i7.381] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v8/i7/381.htm |
Number | Citing Articles |
1 |
Loan Thi-Tung Dang, Anh Nguyen-Tu Bui, Cong Le-Thanh Nguyen, Nhat Chau Truong, Anh Thi-Van Bui, Ngoc Phan Kim, Kiet Dinh Truong, Phuc Van Pham. Stem Cells: Biology and Engineering. Advances in Experimental Medicine and Biology 2017; 1083: 145 doi: 10.1007/5584_2017_127
|
2 |
Dinh-Toi Chu, Thuy Nguyen Thi Phuong, Nguyen Le Bao Tien, Dang Khoa Tran, Vo Van Thanh, Thuy Luu Quang, Dang Tien Truong, Van Huy Pham, Vo Truong Nhu Ngoc, Thien Chu-Dinh, Kushi Kushekhar. An Update on the Progress of Isolation, Culture, Storage, and Clinical Application of Human Bone Marrow Mesenchymal Stem/Stromal Cells. International Journal of Molecular Sciences 2020; 21(3): 708 doi: 10.3390/ijms21030708
|
3 |
Liem Thanh Nguyen, Duc M. Hoang, Kien T. Nguyen, Duc M. Bui, Hieu T. Nguyen, Hong T.A. Le, Van T. Hoang, Hue T. H. Bui, Phuong T.M. Dam, Xuan T.A. Hoang, Anh T.L. Ngo, Hang M. Le, Nhi Y. Phung, Duc M. Vu, Trung T. Duong, Tu D. Nguyen, Lien T. Ha, Hoa T.P. Bui, Hoa K. Nguyen, Michael Heke, Anh V. Bui. Type 2 Diabetes Mellitus Duration and Obesity alter the Efficacy of Autologously Transplanted Bone Marrow-derived Mesenchymal Stem/Stromal Cells. Stem Cells Translational Medicine 2021; 10(9): 1266 doi: 10.1002/sctm.20-0506
|
4 |
Mercedes Lopez-Santalla, Raquel Fernandez-Perez, Marina I. Garin. Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications. Cells 2020; 9(8): 1852 doi: 10.3390/cells9081852
|
5 |
Haifa Abdullah, S Alshammary. Therapeutic application of stem cells in diabetes. Journal of Stem Cell Research & Therapeutics 2020; 6(1): 23 doi: 10.15406/jsrt.2020.06.00137
|
6 |
Joonyub Lee, Kun‐Ho Yoon. Diabetes duration and obesity matter in autologous mesenchymal stem/stromal cell transplantation in type 2 diabetes patients. Journal of Diabetes Investigation 2022; 13(2): 230 doi: 10.1111/jdi.13721
|
7 |
Nathan Norton Ng, Avnesh Sinh Thakor. Locoregional delivery of stem cell–based therapies. Science Translational Medicine 2020; 12(547) doi: 10.1126/scitranslmed.aba4564
|
8 |
Mohammad Amin Javidi, Ayat Kaeidi, Seyedeh Sahar Mortazavi Farsani, Sadegh Babashah, Majid Sadeghizadeh. Investigating curcumin potential for diabetes cell therapy, in vitro and in vivo study. Life Sciences 2019; 239: 116908 doi: 10.1016/j.lfs.2019.116908
|
9 |
Felipe Arroyave, Diana Montaño, Fernando Lizcano. Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells. International Journal of Molecular Sciences 2020; 21(22): 8685 doi: 10.3390/ijms21228685
|
10 |
Chandrashekhar Chavan, Suman Ray, Chandra Mohan Kumar. Stem cell therapy approaches for non-malignant diseases & non-haematological diseases in India: A systematic review. The Indian Journal of Medical Research 2024; 160: 411 doi: 10.25259/ijmr_2141_23
|
11 |
Priyamvada Amol Arte, Kanchanlata Tungare, Mustansir Bhori, Renitta Jobby, Jyotirmoi Aich. Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach. Human Cell 2023; 37(1): 54 doi: 10.1007/s13577-023-01007-0
|
12 |
Alexandra Papadopoulou, Konstantinos I Papadopoulos. Successful lifestyle modifications may underlie umbilical cord-mesenchymal stromal cell effects in type 2 diabetes mellitus. World Journal of Diabetes 2023; 14(3): 347-351 doi: 10.4239/wjd.v14.i3.347
|